<DOC>
	<DOCNO>NCT00435266</DOCNO>
	<brief_summary>Primary percutaneous coronary intervention ( pPCI ) prefer treatment ST elevation myocardial infarction ( STEMI ) . The infarct-related artery ( IRA ) open 90 % patient . However , STEMI patient still end persistent perfusion defect highly variable magnitude indicate adjunctive treatment may add protection tissue damage . Ischemic preconditioning ( IPC ) intervention myocardium threaten ischemia expose short repeat sublethal ischemic episode prior sustain ischemia ( local IPC ) . A systemic response protection remote organ ( remote IPC ( rIPC ) ) also induce . We recently find infarct reduce effect obtain obstruction extremity even though remote stimulus initiate sustained occlusion coronary artery , so-called remote preconditioning ( rPerC ) . The clinical perspective examine rPerC reduce infarct size patient unpredictable ischemia ST elevation myocardial infarction ( STEMI ) . We perform randomize study patient en route pPCI allocate either rPerC standard treatment evaluate whether tissue damage reduce . Effect measure infarct size determine scintigraphy ( final infarct size salvage ) .</brief_summary>
	<brief_title>Remote Ischemic Preconditioning Primary PCI</brief_title>
	<detailed_description>Primary percutaneous coronary intervention ( pPCI ) prefer treatment ST elevation myocardial infarction ( STEMI ) . The infarct-related artery ( IRA ) open 90 % patient . However , STEMI patient still end persistent perfusion defect highly variable magnitude indicate adjunctive treatment may add protection tissue damage . Ischemic preconditioning ( IPC ) intervention myocardium threaten ischemia expose short repeat sublethal ischemic episode prior sustain ischemia ( local IPC ) . A systemic response protection remote organ ( remote IPC ( rIPC ) ) also induce . We recently find infarct reduce effect obtain obstruction extremity even though remote stimulus initiate sustained occlusion coronary artery , so-called remote preconditioning ( rPerC ) . The clinical perspective examine rPerC reduce infarct size patient unpredictable ischemia ST elevation myocardial infarction ( STEMI ) . We perform randomize study patient en route pPCI allocate either rPerC standard treatment evaluate whether tissue damage reduce . Effect measure infarct size determine scintigraphy ( final infarct size salvage ) . Purpose The purpose present study examine utility rPerC STEMI patient treat pPCI . The effect evaluate 1 ) limitation infarct size ( salvage final infarct size ) determine myocardial scintigraphy ( SPECT ) , 2 ) electrocardiographic angiographic sign tissue perfusion , 3 ) release ischemic marker 5 ) echocardiographic marker leave ventricular function 5 ) clinical end-points ( Major Adverse Cardiac Events ( MACE : death , reinfarction , need revascularisation , invalidate stroke ) ) discharge 30 day . Description evaluation ethical aspect study Study patient treat pPCI randomized pretreatment rPerC pretreatment ( control group ) . The randomization take place ambulance local hospital . With aim cause unnecessary delay , pretreatment discontinue patient arrives cath . lab . pretreatment completed.The discomfort connection pretreatment show minimal . Information regard study population The patient recruit among patient admit transferred Department Cardiology B , Skejby Sygehus pPCI treatment STEMI . Review method use rPerC The pretreatment rPerC group comprise 4 x ( 5 min . occlusion right upper extremity follow 5 min . reperfusion ) perform transportation towards Skejby Sygehus . The occlusion obtain inflation blood pressure tourniquet place patient 's right thigh 200 mm Hg 25 mmHg patient 's systolic blood pressure high 200 mm Hg . Angiography The initial angiography perform least two plane administration nitroglycerin 0.2 mg intracoronary film 25 frames/sec . The lesion place centrally picture tip guide catheter visual picture . The final angiography perform plane initial angiography administration nitroglycerin 0.2 mg intracoronary . The angiography film 25 frames/sec . film continue clear projection sinus coronarius . The angiogram film without magnification aim project periphery vessel . The final angiography perform two minute last dilatation - provide patient hemodynamically stable . Percutaneous intervention antithrombotic treatment The patient PCI perform accordance exist procedure guideline Skejby Hospital . Electrocardiogram ( ECG ) monitor Continuous 12-lead ST-monitoring initiated scene use commercial monitor-defibrillator ( LIFEPAK 12 , Medtronic Emergency Response Systems , USA ) , continue transport local hospital ( bypass ) transfer interventional hospital . On arrival interventional hospital traditional ECG electrode replace radiolucent carbon fiber lead wire electrode ( Ambu Blue Sensor QR electrode , Ambu A/S , Denmark ) enable ST-monitoring continue 90 minute follow PCI . The analog ECG signal sample system digitized sample rate 500 Hz processing GE/Marquette Medical Systems 12SL ECG interpretive algorithm . At 30-second interval ST-monitoring program generates median QRST-complex 12 lead base 10-second epoch ECG data . From median QRST-complexes program estimate ST-deviation STM point , halfway J-point QRS complex start T-wave . If 0.1 mV change ST-deviation last 2.5 minute software automatically acquire store 10-second 12-lead ECG waveform . All 12-lead ECG waveform continuous ST-monitoring data transfer personal computer store random key subsequent blind analysis Core Lab . Skejby Sygehus . Biochemical ischemia marker Circulating concentration troponin T ( TnT ) measure arrival , 8-12 hour , 20-24 hour finally 90-102 hour symptom onset . Scintigraphic method Two scintigraphic examination perform determination area risk ( AAR ) , final infarct size ( FIS ) , regional wall motion regional wall thicken respectively . Area risk ( AAR ) : ( That part leave ventricle without perfusion prior PCI ) Determined tracer injection ongoing coronary occlusion mean tracer injection prior PCI image pPCI . Final infarct size ( FIS ) : ( That part leave ventricle without perfusion 1 month PCI ) Determined myocardial scintigraphy rest 1 month pPCI . The following parameter calculate : Salvage : AAR minus FIS ( % leave ventricle ) Salvage index ( % ) : Salvage / AAR . Left ventricular ejection fraction ( LVEF ) ( % ) : ( EDV - ESV ) /EDV . Each myocardial scintigraphy perform administration 700 ± 10 % MBq 99mTc-Sestamibi intravenous bolus injection . Acquisition perform gate SPECT within 8 hour tracer injection . The myocardial perfusion analyze quantitized use interpretation software QPS QGS . At examination partly myocardial perfusion defect percentage leave ventricular myocardium , partly leave ventricular end-diastolic end-systolic volume ( EDV ESV ) partly regional wall motion wall thickening determine . Design data registration The patient randomize pPCI treatment without prior rIPC . All data analyzes study analyze blind regard patient 's randomization . For participant include study , case record form ( CRF ) fill . Definition characteristic effect parameter register data A consecutive patient registration perform characteristic study population registration cause exclusion . Clinical , angiographic procedure relate variable West-Danish Heart Database use . Data evaluation For primary secondary clinical effect parameter , comparative examination rPerC rPerC treat patient group perform . Statistics Dimensioning study : Previous investigation show area risk connection STEMI approximately 30 % leave ventricle . Experiences investigation Department Cardiology B Department Nuclear Medicine , Skejby Sygehus , show final infarct size STEMI patient treat pPCI approximately 15 % . It estimate 20 % reduction infarct size ( e.g . 15 % 12 % ) clinically relevant . With spread infarct size 15 % , accordance previous finding , detection reduction risk type 2 error 80 % ( 2α=0.80 ) require 109 patient group . We plan inclusion total 250 patient secure complete data . The study analyze intention-to-treat principle . A final specification perform unpaired parametric non parametric statistic .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>1 . Acute chest pain equivalent symptom &gt; 30 minute . 2 . Duration symptom &lt; 12 hour . 3 . Cumulated ST elevation &gt; 2 mm two contiguous lead . 4 . Age ≥ 18 year . 5 . Informed consent 1 . Previous bypass surgery . 2 . Pulseless femoral artery . 3 . Left bundle branch block ECG ( LBBB ) . 4 . Acute MI and/or treatment thrombolysis within 30 day . 5 . Patients treat cool patient cardiac arrest . 6 . Diabetic patient 7 . Patients arteriovenous shunt purpose hemodialysis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>myocardial infarction</keyword>
	<keyword>remote</keyword>
	<keyword>precondition</keyword>
	<keyword>perconditioning</keyword>
	<keyword>cardioprotection</keyword>
</DOC>